A case of castration-resistant prostate cancer with liver metastases achieved a complete response by docetaxel chemotherapy

Castration-resistant prostate cancer (CRPC) patients with liver metastases have an extremely poor prognosis. Herein, we report a rare patient who achieved a complete response by docetaxel chemotherapy for this aggressive disease. A 67-year-old Japanese male diagnosed with local prostate cancer [init...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Androl Urol
Glavni autori: Shirotake, Suguru, Umezawa, Yuta, Okabe, Takashi, Kaneko, Go, Kanao, Kent, Nishimoto, Koshiro, Oyama, Masafumi
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2020
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7215045/
https://ncbi.nlm.nih.gov/pubmed/32420190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2020.01.20
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items